BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Op de Beeck A, Eizirik DL. Viral infections in type 1 diabetes mellitus--why the β cells? Nat Rev Endocrinol 2016;12:263-73. [PMID: 27020257 DOI: 10.1038/nrendo.2016.30] [Cited by in Crossref: 146] [Cited by in F6Publishing: 120] [Article Influence: 24.3] [Reference Citation Analysis]
Number Citing Articles
1 [DOI: 10.1101/560193] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Asgari Q, Motazedian MH, Khazanchin A, Mehrabani D, Naderi Shahabadi S. High Prevalence of Toxoplasma gondii Infection in Type I Diabetic Patients. J Parasitol Res 2021;2021:8881908. [PMID: 33628471 DOI: 10.1155/2021/8881908] [Reference Citation Analysis]
3 Bergamin CS, Pérez-Hurtado E, Oliveira L, Gabbay M, Piveta V, Bittencourt C, Russo D, Carmona RC, Sato M, Dib SA. Enterovirus Neutralizing Antibodies, Monocyte Toll Like Receptors Expression and Interleukin Profiles Are Similar Between Non-affected and Affected Siblings From Long-Term Discordant Type 1 Diabetes Multiplex-Sib Families: The Importance of HLA Background. Front Endocrinol (Lausanne) 2020;11:555685. [PMID: 33071971 DOI: 10.3389/fendo.2020.555685] [Reference Citation Analysis]
4 Buitinga M, Callebaut A, Marques Câmara Sodré F, Crèvecoeur I, Blahnik-Fagan G, Yang ML, Bugliani M, Arribas-Layton D, Marré M, Cook DP, Waelkens E, Mallone R, Piganelli JD, Marchetti P, Mamula MJ, Derua R, James EA, Mathieu C, Overbergh L. Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 Diabetes. Diabetes 2018;67:2337-48. [PMID: 30348823 DOI: 10.2337/db18-0295] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
5 Stertz S, Hale BG. Interferon system deficiencies exacerbating severe pandemic virus infections. Trends Microbiol 2021:S0966-842X(21)00060-3. [PMID: 33757684 DOI: 10.1016/j.tim.2021.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
6 Qaisar N, Lin S, Ryan G, Yang C, Oikemus SR, Brodsky MH, Bortell R, Mordes JP, Wang JP. A Critical Role for the Type I Interferon Receptor in Virus-Induced Autoimmune Diabetes in Rats. Diabetes 2017;66:145-57. [PMID: 27999109 DOI: 10.2337/db16-0462] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
7 Jayasimhan A, Ellis DP, Ziegler AI, Slattery RM. Pancreatic ductal cell antigens are important in the development of invasive insulitis in Non-Obese Diabetic mice. J Neuroimmunol 2019;327:1-9. [PMID: 30685070 DOI: 10.1016/j.jneuroim.2019.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Roth R, Lynch K, Hyöty H, Lönnrot M, Driscoll KA, Bennett Johnson S; TEDDY Study Group. The association between stressful life events and respiratory infections during the first 4 years of life: The Environmental Determinants of Diabetes in the Young study. Stress Health 2019;35:289-303. [PMID: 30768831 DOI: 10.1002/smi.2861] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Bezzio C, Della Corte C, Vernero M, Di Luna I, Manes G, Saibeni S. Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations. Therap Adv Gastroenterol 2022;15:175628482211153. [DOI: 10.1177/17562848221115312] [Reference Citation Analysis]
10 Kopan C, Tucker T, Alexander M, Mohammadi MR, Pone EJ, Lakey JRT. Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes. Front Immunol 2018;9:1354. [PMID: 29963051 DOI: 10.3389/fimmu.2018.01354] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
11 Lu T, Lee HC. Coronary Large Conductance Ca2+-Activated K+ Channel Dysfunction in Diabetes Mellitus. Front Physiol 2021;12:750618. [PMID: 34744789 DOI: 10.3389/fphys.2021.750618] [Reference Citation Analysis]
12 Kroger CJ, Clark M, Ke Q, Tisch RM. Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes. Front Immunol 2018;9:1891. [PMID: 30166987 DOI: 10.3389/fimmu.2018.01891] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
13 Iughetti L, Trevisani V, Cattini U, Bruzzi P, Lucaccioni L, Madeo S, Predieri B. COVID-19 and Type 1 Diabetes: Concerns and Challenges. Acta Biomed. 2020;91:e2020033. [PMID: 32921727 DOI: 10.23750/abm.v91i3.10366] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
14 Boddu SK, Aurangabadkar G, Kuchay MS. New onset diabetes, type 1 diabetes and COVID-19.Diabetes Metab Syndr. 2020;14:2211-2217. [PMID: 33395782 DOI: 10.1016/j.dsx.2020.11.012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 28.0] [Reference Citation Analysis]
15 Zhu BT. Pathogenic Mechanism of Autoimmune Diabetes Mellitus in Humans: Potential Role of Streptozotocin-Induced Selective Autoimmunity against Human Islet β-Cells. Cells 2022;11:492. [PMID: 35159301 DOI: 10.3390/cells11030492] [Reference Citation Analysis]
16 Apaolaza PS, Balcacean D, Zapardiel-Gonzalo J, Nelson G, Lenchik N, Akhbari P, Gerling I, Richardson SJ, Rodriguez-Calvo T; nPOD-Virus Group. Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes. Sci Adv 2021;7:eabd6527. [PMID: 33627420 DOI: 10.1126/sciadv.abd6527] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Oshima M, Knoch KP, Diedisheim M, Petzold A, Cattan P, Bugliani M, Marchetti P, Choudhary P, Huang GC, Bornstein SR, Solimena M, Albagli-Curiel O, Scharfmann R. Virus-like infection induces human β cell dedifferentiation. JCI Insight 2018;3:97732. [PMID: 29415896 DOI: 10.1172/jci.insight.97732] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
18 Wu X, Xia Y, He F, Zhu C, Ren W. Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities. Microbiome 2021;9:60. [PMID: 33715629 DOI: 10.1186/s40168-021-01024-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zipris D. Visceral Adipose Tissue: A New Target Organ in Virus-Induced Type 1 Diabetes. Front Immunol 2021;12:702506. [PMID: 34421908 DOI: 10.3389/fimmu.2021.702506] [Reference Citation Analysis]
20 Verdu EF, Danska JS. Common ground: shared risk factors for type 1 diabetes and celiac disease. Nat Immunol 2018;19:685-95. [DOI: 10.1038/s41590-018-0130-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
21 Ramos-Rodríguez M, Raurell-Vila H, Colli ML, Alvelos MI, Subirana-Granés M, Juan-Mateu J, Norris R, Turatsinze JV, Nakayasu ES, Webb-Robertson BM, Inshaw JRJ, Marchetti P, Piemonti L, Esteller M, Todd JA, Metz TO, Eizirik DL, Pasquali L. The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes. Nat Genet 2019;51:1588-95. [PMID: 31676868 DOI: 10.1038/s41588-019-0524-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 13.7] [Reference Citation Analysis]
22 Coomans de Brachène A, Castela A, Musuaya AE, Marselli L, Marchetti P, Eizirik DL. Endogenous mitochondrial double-stranded RNA is not an activator of the type I interferon response in human pancreatic beta cells. Auto Immun Highlights 2021;12:6. [PMID: 33773604 DOI: 10.1186/s13317-021-00148-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Pugliese A. Autoreactive T cells in type 1 diabetes. J Clin Invest 2017;127:2881-91. [PMID: 28762987 DOI: 10.1172/JCI94549] [Cited by in Crossref: 129] [Cited by in F6Publishing: 85] [Article Influence: 25.8] [Reference Citation Analysis]
24 Isaacs SR, Foskett DB, Maxwell AJ, Ward EJ, Faulkner CL, Luo JYX, Rawlinson WD, Craig ME, Kim KW. Viruses and Type 1 Diabetes: From Enteroviruses to the Virome. Microorganisms 2021;9:1519. [PMID: 34361954 DOI: 10.3390/microorganisms9071519] [Reference Citation Analysis]
25 Alonso-magdalena P, Tudurí E, Marroquí L, Quesada I, Sargis RM, Nadal A. Toxic Effects of Common Environmental Pollutants in Pancreatic β-Cells and the Onset of Diabetes Mellitus. Encyclopedia of Endocrine Diseases. Elsevier; 2019. pp. 764-75. [DOI: 10.1016/b978-0-12-801238-3.64325-8] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Oleson BJ, Corbett JA. Dual Role of Nitric Oxide in Regulating the Response of β Cells to DNA Damage. Antioxid Redox Signal 2018;29:1432-45. [PMID: 28978225 DOI: 10.1089/ars.2017.7351] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
27 Nekoua MP, Bertin A, Sane F, Gimeno JP, Fournier I, Salzet M, Engelmann I, Alidjinou EK, Hober D. Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation. Microorganisms 2021;9:1125. [PMID: 34067388 DOI: 10.3390/microorganisms9061125] [Reference Citation Analysis]
28 Li G, Chen Z, Lv Z, Li H, Chang D, Lu J. Diabetes Mellitus and COVID-19: Associations and Possible Mechanisms. Int J Endocrinol 2021;2021:7394378. [PMID: 33859687 DOI: 10.1155/2021/7394378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
29 Salami F, Lee HS, Freyhult E, Elding Larsson H, Lernmark Å, Törn C; TEDDY Study Group. Reduction in White Blood Cell, Neutrophil, and Red Blood Cell Counts Related to Sex, HLA, and Islet Autoantibodies in Swedish TEDDY Children at Increased Risk for Type 1 Diabetes. Diabetes 2018;67:2329-36. [PMID: 30104249 DOI: 10.2337/db18-0355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
30 Lombardi A, Tomer Y. Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress. J Autoimmun 2017;80:48-55. [PMID: 28238527 DOI: 10.1016/j.jaut.2017.02.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
31 Marroqui L, Dos Santos RS, Op de Beeck A, Coomans de Brachène A, Marselli L, Marchetti P, Eizirik DL. Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes. Diabetologia 2017;60:656-67. [PMID: 28062922 DOI: 10.1007/s00125-016-4201-3] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 14.6] [Reference Citation Analysis]
32 Genoni A, Canducci F, Rossi A, Broccolo F, Chumakov K, Bono G, Salerno-Uriarte J, Salvatoni A, Pugliese A, Toniolo A. Revealing enterovirus infection in chronic human disorders: An integrated diagnostic approach. Sci Rep 2017;7:5013. [PMID: 28694527 DOI: 10.1038/s41598-017-04993-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
33 Hyöty H, Leon F, Knip M. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B. Expert Rev Vaccines 2018;17:1071-83. [PMID: 30449209 DOI: 10.1080/14760584.2018.1548281] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
34 Valenzuela-Vallejo L, López-Ramírez SA, Morales-Burton V, Aguilera-Martínez S, Álvarez-Olmos MI, Durán-Ventura P. Pediatric diabetic ketoacidosis as type 1 diabetes debut with concurrent SARS-CoV-2 infection: A case report. SAGE Open Med Case Rep 2022;10:2050313X221097263. [PMID: 35585855 DOI: 10.1177/2050313X221097263] [Reference Citation Analysis]
35 Baekkeskov S, Hubbell JA, Phelps EA. Bioengineering strategies for inducing tolerance in autoimmune diabetes. Adv Drug Deliv Rev 2017;114:256-65. [PMID: 28625830 DOI: 10.1016/j.addr.2017.06.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
36 Alvelos MI, Juan-Mateu J, Colli ML, Turatsinze JV, Eizirik DL. When one becomes many-Alternative splicing in β-cell function and failure. Diabetes Obes Metab 2018;20 Suppl 2:77-87. [PMID: 30230174 DOI: 10.1111/dom.13388] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
37 Sgrazzutti L, Sansone F, Attanasi M, Di Pillo S, Chiarelli F. Coaggregation of Asthma and Type 1 Diabetes in Children: A Narrative Review. Int J Mol Sci 2021;22:5757. [PMID: 34071190 DOI: 10.3390/ijms22115757] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Stafford JD, Shaheen ZR, Yeo CT, Corbett JA. Inhibition of mitochondrial oxidative metabolism attenuates EMCV replication and protects β-cells from virally mediated lysis. J Biol Chem 2020;295:16655-64. [PMID: 32972972 DOI: 10.1074/jbc.RA120.014851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Eizirik DL, Op de Beeck A. Coxsackievirus and Type 1 Diabetes Mellitus: The Wolf's Footprints. Trends Endocrinol Metab 2018;29:137-9. [PMID: 29326001 DOI: 10.1016/j.tem.2017.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
40 Kolb H, von Herrath M. Immunotherapy for Type 1 Diabetes: Why Do Current Protocols Not Halt the Underlying Disease Process? Cell Metabolism 2017;25:233-41. [DOI: 10.1016/j.cmet.2016.10.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
41 Pusch E, Renz H, Skevaki C. Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? Allergo J Int 2018;27:79-96. [PMID: 32226720 DOI: 10.1007/s40629-018-0056-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
42 Colli ML, Hill JLE, Marroquí L, Chaffey J, Dos Santos RS, Leete P, Coomans de Brachène A, Paula FMM, Op de Beeck A, Castela A, Marselli L, Krogvold L, Dahl-Jorgensen K, Marchetti P, Morgan NG, Richardson SJ, Eizirik DL. PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction. EBioMedicine 2018;36:367-75. [PMID: 30269996 DOI: 10.1016/j.ebiom.2018.09.040] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 15.3] [Reference Citation Analysis]
43 Sales Luis M, Alcafache M, Ferreira S, Fitas AL, Simões Pereira J, Caramalho Í, Lopes L, Limbert C. Children with type 1 diabetes of early age at onset - immune and metabolic phenotypes. J Pediatr Endocrinol Metab 2019;32:935-41. [PMID: 31280235 DOI: 10.1515/jpem-2019-0103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Nakayasu ES, Qian WJ, Evans-Molina C, Mirmira RG, Eizirik DL, Metz TO. The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes. Expert Rev Proteomics 2019;16:569-82. [PMID: 31232620 DOI: 10.1080/14789450.2019.1634548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
45 Klocperk A, Vcelakova J, Vrabcova P, Zentsova I, Petruzelkova L, Sumnik Z, Pruhova S, Sediva A, Parackova Z. Elevated Biomarkers of NETosis in the Serum of Pediatric Patients With Type 1 Diabetes and Their First-Degree Relatives. Front Immunol 2021;12:699386. [PMID: 34305937 DOI: 10.3389/fimmu.2021.699386] [Reference Citation Analysis]
46 Norris JM, Johnson RK, Stene LC. Type 1 diabetes-early life origins and changing epidemiology. Lancet Diabetes Endocrinol 2020;8:226-38. [PMID: 31999944 DOI: 10.1016/S2213-8587(19)30412-7] [Cited by in Crossref: 81] [Cited by in F6Publishing: 51] [Article Influence: 40.5] [Reference Citation Analysis]
47 Faulkner CL, Luo YX, Isaacs S, Rawlinson WD, Craig ME, Kim KW. The virome in early life and childhood and development of islet autoimmunity and type 1 diabetes: A systematic review and meta-analysis of observational studies. Rev Med Virol 2020;:e2209. [PMID: 33378601 DOI: 10.1002/rmv.2209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
48 Qi Z, Hu H, Wang Z, Wang G, Li Y, Zhao X, Feng Y, Huo X, Sun J, Feng Q, Liu Y, Wang N, Guo C, Li Y, Wang R, Hu J. Antibodies against H1N1 influenza virus cross-react with α-cells of pancreatic islets. J Diabetes Investig 2018;9:265-9. [PMID: 28477380 DOI: 10.1111/jdi.12690] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
49 Needell JC, Zipris D. The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis. Curr Diab Rep. 2016;16:89. [PMID: 27523648 DOI: 10.1007/s11892-016-0781-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
50 Rodriguez-Calvo T, Richardson SJ, Pugliese A. Pancreas Pathology During the Natural History of Type 1 Diabetes. Curr Diab Rep 2018;18:124. [PMID: 30293191 DOI: 10.1007/s11892-018-1084-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
51 Clarke SA, Phylactou M, Patel B, Mills EG, Muzi B, Izzi-Engbeaya C, Khoo B, Meeran K, Comninos AN, Abbara A, Tan T, Oliver N, Dhillo WS. Preserved C-peptide in survivors of COVID-19: Post hoc analysis. Diabetes Obes Metab 2022;24:570-4. [PMID: 34850532 DOI: 10.1111/dom.14608] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Srivastava A, Rockman-Greenberg C, Sareen N, Lionetti V, Dhingra S. An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning β-cell survival and cardiovascular conditions in diabetic patients. Mol Cell Biochem 2022. [PMID: 35235124 DOI: 10.1007/s11010-022-04396-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Brawerman G, Thompson PJ. Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside. Biomolecules 2020;10:E1681. [PMID: 33339173 DOI: 10.3390/biom10121681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 [DOI: 10.1101/2020.07.23.208041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
55 Zaheer A, Zaheer F, Saeed H, Tahir Z, Tahir MW. A Review of Alternative Treatment Options in Diabetic Polyneuropathy. Cureus 2021;13:e14600. [PMID: 34040901 DOI: 10.7759/cureus.14600] [Reference Citation Analysis]
56 Hegazy WAH, Rajab AAH, Abu Lila AS, Abbas HA. Anti-diabetics and antimicrobials: Harmony of mutual interplay. World J Diabetes 2021; 12(11): 1832-1855 [PMID: 34888011 DOI: 10.4239/wjd.v12.i11.1832] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
57 Colli ML, Ramos-Rodríguez M, Nakayasu ES, Alvelos MI, Lopes M, Hill JLE, Turatsinze JV, Coomans de Brachène A, Russell MA, Raurell-Vila H, Castela A, Juan-Mateu J, Webb-Robertson BM, Krogvold L, Dahl-Jorgensen K, Marselli L, Marchetti P, Richardson SJ, Morgan NG, Metz TO, Pasquali L, Eizirik DL. An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells. Nat Commun 2020;11:2584. [PMID: 32444635 DOI: 10.1038/s41467-020-16327-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
58 Wang YN, Liu S, Jia T, Feng Y, Xu X, Zhang D. T Cell Protein Tyrosine Phosphatase in Glucose Metabolism. Front Cell Dev Biol 2021;9:682947. [PMID: 34268308 DOI: 10.3389/fcell.2021.682947] [Reference Citation Analysis]
59 Nyalwidhe JO, Jurczyk A, Satish B, Redick S, Qaisar N, Trombly MI, Vangala P, Racicot R, Bortell R, Harlan DM, Greiner DL, Brehm MA, Nadler JL, Wang JP. Proteomic and Transcriptional Profiles of Human Stem Cell-Derived β Cells Following Enteroviral Challenge. Microorganisms 2020;8:E295. [PMID: 32093375 DOI: 10.3390/microorganisms8020295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
60 Rodriguez-Calvo T, Zapardiel-Gonzalo J, Amirian N, Castillo E, Lajevardi Y, Krogvold L, Dahl-Jørgensen K, von Herrath MG. Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset. Diabetes 2017;66:1334-45. [PMID: 28137793 DOI: 10.2337/db16-1343] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 11.0] [Reference Citation Analysis]
61 Ghosh R, Dubey S, Roy D, Ray A, Pandit A, Ray BK, Benito-León J. Choreo-ballistic movements heralding COVID-19 induced diabetic ketoacidosis. Diabetes Metab Syndr 2021;15:913-7. [PMID: 33915346 DOI: 10.1016/j.dsx.2021.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
62 Gonzalez-Moro I, Olazagoitia-Garmendia A, Colli ML, Cobo-Vuilleumier N, Postler TS, Marselli L, Marchetti P, Ghosh S, Gauthier BR, Eizirik DL, Castellanos-Rubio A, Santin I. The T1D-associated lncRNA Lnc13 modulates human pancreatic β cell inflammation by allele-specific stabilization of STAT1 mRNA. Proc Natl Acad Sci U S A 2020;117:9022-31. [PMID: 32284404 DOI: 10.1073/pnas.1914353117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
63 Xia Y, Xie Z, Huang G, Zhou Z. Incidence and trend of type 1 diabetes and the underlying environmental determinants. Diabetes Metab Res Rev. 2019;35:e3075. [PMID: 30207035 DOI: 10.1002/dmrr.3075] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 11.5] [Reference Citation Analysis]
64 Cojocaru FD, Botezat D, Gardikiotis I, Uritu CM, Dodi G, Trandafir L, Rezus C, Rezus E, Tamba BI, Mihai CT. Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Pharmaceutics 2020;12:E171. [PMID: 32085535 DOI: 10.3390/pharmaceutics12020171] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 31.5] [Reference Citation Analysis]
65 Sebastian-delaCruz M, Gonzalez-Moro I, Olazagoitia-Garmendia A, Castellanos-Rubio A, Santin I. The Role of lncRNAs in Gene Expression Regulation through mRNA Stabilization. Noncoding RNA 2021;7:3. [PMID: 33466464 DOI: 10.3390/ncrna7010003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Kirak O, Ke E, Yang KY, Schwarz A, Plate L, Nham A, Abadejos JR, Valencia A, Wiseman RL, Lui KO, Ku M. Premature Activation of Immune Transcription Programs in Autoimmune-Predisposed Mouse Embryonic Stem Cells and Blastocysts. Int J Mol Sci 2020;21:E5743. [PMID: 32796510 DOI: 10.3390/ijms21165743] [Reference Citation Analysis]
67 Mine K, Yoshikai Y, Takahashi H, Mori H, Anzai K, Nagafuchi S. Genetic Susceptibility of the Host in Virus-Induced Diabetes. Microorganisms 2020;8:E1133. [PMID: 32727064 DOI: 10.3390/microorganisms8081133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
68 Singh R, Gupta S, Kumar P. The Role of Nanotechnology in Antiviral Regime: An Overview. Nano LIFE 2022;12:2130011. [DOI: 10.1142/s1793984421300119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Lincez PJ, Shanina I, Horwitz MS. Changes in MDA5 and TLR3 Sensing of the Same Diabetogenic Virus Result in Different Autoimmune Disease Outcomes. Front Immunol 2021;12:751341. [PMID: 34804036 DOI: 10.3389/fimmu.2021.751341] [Reference Citation Analysis]
70 Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt PI. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016;473:4527-4550. [PMID: 27941030 DOI: 10.1042/bcj20160503c] [Cited by in Crossref: 305] [Cited by in F6Publishing: 150] [Article Influence: 61.0] [Reference Citation Analysis]
71 Eizirik DL, Pasquali L, Cnop M. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol 2020;16:349-62. [PMID: 32398822 DOI: 10.1038/s41574-020-0355-7] [Cited by in Crossref: 170] [Cited by in F6Publishing: 130] [Article Influence: 85.0] [Reference Citation Analysis]
72 Niklasson B, Klitz W, Juntti-Berggren L, Berggren PO, Lindquist L. Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials. Viral Immunol 2020;33:594-9. [PMID: 32758075 DOI: 10.1089/vim.2020.0039] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Toniolo A, Cassani G, Puggioni A, Rossi A, Colombo A, Onodera T, Ferrannini E. The diabetes pandemic and associated infections: suggestions for clinical microbiology. Rev Med Microbiol 2019;30:1-17. [PMID: 30662163 DOI: 10.1097/MRM.0000000000000155] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
74 Albuali WH, AlGhamdi NA. Diabetic ketoacidosis precipitated by atypical coronavirus disease in a newly diagnosed diabetic girl. J Taibah Univ Med Sci 2021;16:628-31. [PMID: 34177416 DOI: 10.1016/j.jtumed.2021.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Caruso P, Longo M, Esposito K, Maiorino MI. Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak? Diabetes Res Clin Pract. 2020;164:108219. [PMID: 32442555 DOI: 10.1016/j.diabres.2020.108219] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
76 Needell JC, Zipris D. Rat Models of Virus-Induced Type 1 Diabetes. Methods Mol Biol 2020;2128:107-14. [PMID: 32180189 DOI: 10.1007/978-1-0716-0385-7_8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Tetz G, Brown SM, Hao Y, Tetz V. Type 1 Diabetes: an Association Between Autoimmunity, the Dynamics of Gut Amyloid-producing E. coli and Their Phages. Sci Rep 2019;9:9685. [PMID: 31273267 DOI: 10.1038/s41598-019-46087-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
78 Li Y, Ding X, Tian X, Zheng J, Ding C, Li X, Hu X, Qiao Y, Wang Y, Xue W. Islet transplantation modulates macrophage to induce immune tolerance and angiogenesis of islet tissue in type I diabetes mice model. Aging (Albany NY) 2020;12:24023-32. [PMID: 33221752 DOI: 10.18632/aging.104085] [Reference Citation Analysis]
79 Chowdhury S, Goswami S. COVID-19 and type 1 diabetes: dealing with the difficult duo. Int J Diabetes Dev Ctries. 2020: 1-6. [PMID: 32837091 DOI: 10.1007/s13410-020-00846-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
80 Sayed S. COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine. Prim Care Diabetes 2021;15:4-9. [PMID: 32912711 DOI: 10.1016/j.pcd.2020.08.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
81 Fignani D, Licata G, Brusco N, Nigi L, Grieco GE, Marselli L, Overbergh L, Gysemans C, Colli ML, Marchetti P, Mathieu C, Eizirik DL, Sebastiani G, Dotta F. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature. Front Endocrinol (Lausanne) 2020;11:596898. [PMID: 33281748 DOI: 10.3389/fendo.2020.596898] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 19.5] [Reference Citation Analysis]
82 Viswanathan V, Puvvula A, Jamthikar AD, Saba L, Johri AM, Kotsis V, Khanna NN, Dhanjil SK, Majhail M, Misra DP, Agarwal V, Kitas GD, Sharma AM, Kolluri R, Naidu S, Suri JS. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review. World J Diabetes 2021; 12(3): 215-237 [PMID: 33758644 DOI: 10.4239/wjd.v12.i3.215] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
83 Houeiss P, Luce S, Boitard C. Environmental Triggering of Type 1 Diabetes Autoimmunity. Front Endocrinol 2022;13:933965. [DOI: 10.3389/fendo.2022.933965] [Reference Citation Analysis]
84 El-Hawary SS, Mubarek MM, Lotfy RA, Hassan AR, Sobeh M, Okba MM. Validation of Antidiabetic Potential of Gymnocarpos decandrus Forssk. Nat Prod Res 2020;:1-6. [PMID: 32791855 DOI: 10.1080/14786419.2020.1805608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Dorajoo R, Ali Y, Tay VSY, Kang J, Samydurai S, Liu J, Boehm BO. Single-cell transcriptomics of East-Asian pancreatic islets cells. Sci Rep 2017;7:5024. [PMID: 28694456 DOI: 10.1038/s41598-017-05266-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
86 Hober D, Alidjinou EK. Diabetes: Towards a coxsackievirus B-based vaccine to combat T1DM. Nat Rev Endocrinol 2018;14:131-2. [PMID: 29327705 DOI: 10.1038/nrendo.2017.184] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
87 Nekoua MP, Dechaumes A, Sane F, Alidjinou EK, Moutairou K, Yessoufou A, Hober D. Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells. Microorganisms 2020;8:E989. [PMID: 32630332 DOI: 10.3390/microorganisms8070989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
88 Dou Y, Yim HC, Kirkwood CD, Williams BR, Sadler AJ. The innate immune receptor MDA5 limits rotavirus infection but promotes cell death and pancreatic inflammation. EMBO J 2017;36:2742-57. [PMID: 28851763 DOI: 10.15252/embj.201696273] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
89 Colli ML, Szymczak F, Eizirik DL. Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes. Front Endocrinol (Lausanne) 2020;11:568446. [PMID: 33042023 DOI: 10.3389/fendo.2020.568446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Gautam A, Akauliya M, Thapa B, Park BK, Kim D, Kim J, Lee K, Choi KC, Bae JY, Park MS, Lee Y, Kwon HJ. Abdominal and Pelvic Organ Failure Induced by Intraperitoneal Influenza A Virus Infection in Mice. Front Microbiol 2020;11:1713. [PMID: 32765481 DOI: 10.3389/fmicb.2020.01713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Yang L, Han X, Zhang C, Sun C, Huang S, Xiao W, Gao Y, Liang Q, Luo F, Lu W, Fu J, Zhou Y. Hsa_circ_0060450 Negatively Regulates Type I Interferon-Induced Inflammation by Serving as miR-199a-5p Sponge in Type 1 Diabetes Mellitus. Front Immunol 2020;11:576903. [PMID: 33133095 DOI: 10.3389/fimmu.2020.576903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
92 Mine K, Hirakawa K, Kondo S, Minami M, Okada A, Tsutsu N, Yokogawa Y, Hibio Y, Kojima F, Fujimoto S, Kurisaki H, Anzai K, Yoshikai Y, Nagafuchi S; West Japan Pathogenesis of Diabetes Study Group. Subtyping of Type 1 Diabetes as Classified by Anti-GAD Antibody, IgE Levels, and Tyrosine kinase 2 (TYK2) Promoter Variant in the Japanese. EBioMedicine 2017;23:46-51. [PMID: 28826655 DOI: 10.1016/j.ebiom.2017.08.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
93 Jia YF, Jeeva S, Xu J, Heppelmann CJ, Jang JS, Slama MQ, Tapadar S, Oyelere AK, Kang SM, Matveyenko AV, Peterson QP, Shin CH. TBK1 regulates regeneration of pancreatic β-cells. Sci Rep 2020;10:19374. [PMID: 33168920 DOI: 10.1038/s41598-020-76600-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Marroqui L, Perez-Serna AA, Babiloni-Chust I, Dos Santos RS. Type I interferons as key players in pancreatic β-cell dysfunction in type 1 diabetes. Int Rev Cell Mol Biol 2021;359:1-80. [PMID: 33832648 DOI: 10.1016/bs.ircmb.2021.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Dehghani Firouzabadi F, Dehghani Firouzabadi M, Moosaie F, Rafiee S, Esteghamati A. Type 1 diabetic manifestations in a young man triggered by COVID-19. Clin Case Rep 2021;9:e04211. [PMID: 34178332 DOI: 10.1002/ccr3.4211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Sherif EM, Elhenawy YI, Matter RM, Aly HH, Thabet RA, Fereig YA. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt. J Pediatr Endocrinol Metab 2021;34:925-36. [PMID: 33882200 DOI: 10.1515/jpem-2021-0099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Balcha SA, Demisse AG, Mishra R, Vartak T, Cousminer DL, Hodge KM, Voight BF, Lorenz K, Schwartz S, Jerram ST, Gamper A, Holmes A, Wilson HF, Williams AJK, Grant SFA, Leslie RD, Phillips DIW, Trimble ER. Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia. Diabetologia 2020;63:2158-68. [PMID: 32705316 DOI: 10.1007/s00125-020-05229-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
98 Jiang H, Li Y, Shen M, Liang Y, Qian Y, Dai H, Xu K, Xu X, Lv H, Zhang J, Yang T, Fu Q. Interferon-α promotes MHC I antigen presentation of islet β cells through STAT1-IRF7 pathway in type 1 diabetes. Immunology 2022. [PMID: 35298836 DOI: 10.1111/imm.13468] [Reference Citation Analysis]
99 Yin Z, Wu Y, Zhu R, Xu L, Lin Y, Yang H, Fu W, Huang Q, Zhang D, Wang J, Wang W, Wang Y, Cheng T, Xia N. Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation. Virol Sin 2021. [PMID: 34581960 DOI: 10.1007/s12250-021-00444-1] [Reference Citation Analysis]
100 Qaisar N, Jurczyk A, Wang JP. Potential role of type I interferon in the pathogenic process leading to type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2018;25:94-100. [PMID: 29369915 DOI: 10.1097/MED.0000000000000399] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
101 Ruiz PLD, Tapia G, Bakken IJ, Håberg SE, Hungnes O, Gulseth HL, Stene LC. Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study. Diabetologia 2018;61:1996-2004. [PMID: 29934759 DOI: 10.1007/s00125-018-4662-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
102 Dos Santos RS, Marroqui L, Grieco FA, Marselli L, Suleiman M, Henz SR, Marchetti P, Wernersson R, Eizirik DL. Protective Role of Complement C3 Against Cytokine-Mediated β-Cell Apoptosis. Endocrinology 2017;158:2503-21. [PMID: 28582497 DOI: 10.1210/en.2017-00104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
103 Piganelli JD, Mamula MJ, James EA. The Role of β Cell Stress and Neo-Epitopes in the Immunopathology of Type 1 Diabetes. Front Endocrinol (Lausanne) 2020;11:624590. [PMID: 33679609 DOI: 10.3389/fendo.2020.624590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
104 Clark M, Kroger CJ, Tisch RM. Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response. Front Immunol. 2017;8:1898. [PMID: 29312356 DOI: 10.3389/fimmu.2017.01898] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
105 Ibrahim S, Monaco GSF, Sims EK. Not so sweet and simple: impacts of SARS-CoV-2 on the β cell. Islets 2021;13:66-79. [PMID: 33970787 DOI: 10.1080/19382014.2021.1909970] [Reference Citation Analysis]
106 Alper CA, Larsen CE, Trautwein MR, Alford DR. A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes. J Autoimmun 2019;96:123-33. [PMID: 30309752 DOI: 10.1016/j.jaut.2018.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
107 Coomans de Brachène A, Castela A, Op de Beeck A, Mirmira RG, Marselli L, Marchetti P, Masse C, Miao W, Leit S, Evans-Molina C, Eizirik DL. Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes. Diabetes Obes Metab 2020;22:1827-36. [PMID: 32476252 DOI: 10.1111/dom.14104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
108 Eizirik DL, Szymczak F, Alvelos MI, Martin F. From Pancreatic β-Cell Gene Networks to Novel Therapies for Type 1 Diabetes. Diabetes 2021;70:1915-25. [PMID: 34417266 DOI: 10.2337/dbi20-0046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Pusch E, Renz H, Skevaki C. Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution? Allergo J 2018;27:28-45. [PMID: 32300267 DOI: 10.1007/s15007-018-1580-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
110 Dos Santos RS, Marroqui L, Velayos T, Olazagoitia-Garmendia A, Jauregi-Miguel A, Castellanos-Rubio A, Eizirik DL, Castaño L, Santin I. DEXI, a candidate gene for type 1 diabetes, modulates rat and human pancreatic beta cell inflammation via regulation of the type I IFN/STAT signalling pathway. Diabetologia 2019;62:459-72. [PMID: 30478640 DOI: 10.1007/s00125-018-4782-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
111 Montefusco L, Bolla AM, Fiorina P. Should we expect a wave of type 1 diabetes following SARS‐CoV‐2 pandemic? Diabetes Metabolism Res 2022;38. [DOI: 10.1002/dmrr.3529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Chang DJ, Moin T. Coronavirus disease 2019 and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2021;28:35-42. [PMID: 33278126 DOI: 10.1097/MED.0000000000000598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
113 Phillips N, Ke E, Nham A, Seidl M, Freeman B, Abadejos JR, Xiao C, Nemazee D, Ku M, Kirak O. Prediabetes Induced by a Single Autoimmune B Cell Clone. Front Immunol 2020;11:1073. [PMID: 32625203 DOI: 10.3389/fimmu.2020.01073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Rodriguez-Calvo T. Enteroviral Infections as a Trigger for Type 1 Diabetes. Curr Diab Rep 2018;18:106. [PMID: 30232567 DOI: 10.1007/s11892-018-1077-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
115 Fulci V, Stronati L, Cucchiara S, Laudadio I, Carissimi C. Emerging Roles of Gut Virome in Pediatric Diseases. Int J Mol Sci 2021;22:4127. [PMID: 33923593 DOI: 10.3390/ijms22084127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Surendar J, Indulekha K, Hoerauf A, Hübner MP. Immunomodulation by helminths: Similar impact on type 1 and type 2 diabetes? Parasite Immunol 2017;39. [PMID: 27862000 DOI: 10.1111/pim.12401] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
117 Mallone R, Eizirik DL. Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes? Diabetologia 2020;63:1999-2006. [PMID: 32894310 DOI: 10.1007/s00125-020-05176-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
118 Szymczak F, Colli ML, Mamula MJ, Evans-Molina C, Eizirik DL. Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis. Sci Adv 2021;7:eabd7600. [PMID: 33523973 DOI: 10.1126/sciadv.abd7600] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
119 Mastracci TL, Turatsinze JV, Book BK, Restrepo IA, Pugia MJ, Wiebke EA, Pescovitz MD, Eizirik DL, Mirmira RG. Distinct gene expression pathways in islets from individuals with short- and long-duration type 1 diabetes. Diabetes Obes Metab 2018;20:1859-67. [PMID: 29569324 DOI: 10.1111/dom.13298] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
120 Craig ME, Kim KW, Isaacs SR, Penno MA, Hamilton-Williams EE, Couper JJ, Rawlinson WD. Early-life factors contributing to type 1 diabetes. Diabetologia 2019;62:1823-34. [PMID: 31451871 DOI: 10.1007/s00125-019-4942-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
121 Lönnrot M, Lynch KF, Elding Larsson H, Lernmark Å, Rewers MJ, Törn C, Burkhardt BR, Briese T, Hagopian WA, She JX, Simell OG, Toppari J, Ziegler AG, Akolkar B, Krischer JP, Hyöty H; TEDDY Study Group. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study. Diabetologia 2017;60:1931-40. [PMID: 28770319 DOI: 10.1007/s00125-017-4365-5] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 11.6] [Reference Citation Analysis]
122 Zhang X, Ma Z, Song E, Xu T. Islet organoid as a promising model for diabetes. Protein Cell 2021. [PMID: 33751396 DOI: 10.1007/s13238-021-00831-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
123 Grieco FA, Sebastiani G, Juan-Mateu J, Villate O, Marroqui L, Ladrière L, Tugay K, Regazzi R, Bugliani M, Marchetti P, Dotta F, Eizirik DL. MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic β-Cells. Diabetes 2017;66:100-12. [PMID: 27737950 DOI: 10.2337/db16-0592] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 9.5] [Reference Citation Analysis]